Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Mol Genet Metab ; 129(3): 207-212, 2020 03.
Artículo en Inglés | MEDLINE | ID: mdl-31952925

RESUMEN

Hyperammonia due to ornithine transcarbamylase deficiency (OTCD) can cause a range of deficiencies in domains of executive function and working memory. Only a few fMRI studies have focused on neuroimaging data in a population with OTCD. Yet, there is a need for monitoring the disease progression and neurocognitive function in this population. In this study, we used a non-invasive neuroimaging technique, functional Near Infrared Spectroscopy (fNIRS), to examine the hemodynamics of prefrontal cortex (PFC) based on neural activation in an OTCD population. Using fNIRS, we measured the activation in PFC of the participants while performing the Stroop task. Behavioral assessment such as reaction time and correct response were recorded. We investigated the difference in behavioral measures as well as brain activation in left and right PFC in patients with OTCD and controls. Results revealed a distinction in left PFC activation between controls and patients with OTCD, where control subjects showed higher task related activation increase. Subjects with OTCD also exhibited bilateral increase in PFC activation. There was no significant difference in response time or correct response between the two groups. Our findings suggest the alterations in neurocognitive function of PFC in OTCD compared to the controls despite the behavioral profiles exhibiting no such differences. This is a first study using fNIRS to examine a neurocognitive function in OTCD population and can provide a novel insight into the screening of OTCD progression and examining neurocognitive changes.


Asunto(s)
Cognición/fisiología , Hemodinámica/fisiología , Neuroimagen/métodos , Enfermedad por Deficiencia de Ornitina Carbamoiltransferasa/diagnóstico por imagen , Enfermedad por Deficiencia de Ornitina Carbamoiltransferasa/fisiopatología , Corteza Prefrontal/fisiopatología , Espectroscopía Infrarroja Corta/métodos , Adolescente , Adulto , Función Ejecutiva/fisiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Neuroimagen/instrumentación , Tiempo de Reacción/fisiología , Espectroscopía Infrarroja Corta/instrumentación
2.
Medicine (Baltimore) ; 98(33): e16827, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31415401

RESUMEN

INTRODUCTION: Ornithine transcarbamylase deficiency (OTCD) is a common metabolic disease of urea circulation disorder. We reported the clinical, brain imaging and genetic characteristics of 2 cases with OTCD. The patients' clinical features, novel gene mutations, cranial MR specific imaging changes and blood tandem mass spectrometry, and urine gas chromatography-mass spectrometry were, retrospectively, analyzed. PATIENT CONCERNS: Patient 1 was a 1.6-year-old female. She was admitted to the hospital with 2-months history of general irritability and disturbance of consciousness for a day. Patient 2 was a 3.7-year-old female. She was admitted to the hospital due to decline of language ability and irritability for 5 days. Blood tandem mass spectrometry and urine gas chromatography-mass spectrometry showed uracil and orotate increased significantly in urine while amino acids in the urea cycle ring were in the normal range. The features of brain MRI are consistent with those of urea circulatory disorders. Gene detection showed 1 novel mutation in the OTC gene (c.658C>T) in patient 1 and, 1 novel mutation (c.298+2T>G) in the OTC gene in patient 2. DIAGNOSIS: Combined with metabolic screening and gene detection, both patients were diagnosed with OTCD. INTERVENTIONS: The patients' condition improved after following a low protein diet and receiving treatments for decreasing blood ammonia, energy supplement, correcting acid-base imbalance, and other symptomatic treatments. OUTCOMES: After prompt symptomatic treatment, the consciousness and cognition of the children improved. Besides, liver function also improved significantly. CONCLUSIONS: For patients with neurological symptoms and unexplained increase in transaminase and ammonia, OTCD should be considered as a possible diagnosis. Brain MRI can help the diagnosis of genetic metabolic encephalopathy and reflect the level of brain injury. Metabolic screening and genetic detection are helpful to make a confirmed diagnosis.


Asunto(s)
Cromatografía de Gases y Espectrometría de Masas , Imagen por Resonancia Magnética , Enfermedad por Deficiencia de Ornitina Carbamoiltransferasa/diagnóstico por imagen , Espectrometría de Masas en Tándem , Preescolar , Femenino , Humanos , Lactante , Enfermedad por Deficiencia de Ornitina Carbamoiltransferasa/genética
3.
Mol Genet Metab ; 125(3): 235-240, 2018 11.
Artículo en Inglés | MEDLINE | ID: mdl-30197275

RESUMEN

BACKGROUND: Continuous EEG studies demonstrate that neonates with seizures due to cerebral pathology, such as hypoxia ischemia, exhibit predominantly electrographic seizures (i.e. those only detected with EEG because they lack clinical features). Previous small case series demonstrate EEG changes and seizures during hyperammonemia associated with inborn errors of metabolism (IEM) but there are no reports utilizing continuous EEG in these conditions. OBJECTIVE: To characterize seizures and evaluate the utility of continuous EEG recording during hyperammonemia due to inborn errors of metabolism. METHODS: We retrospectively reviewed medical records and EEG tracings of neonates who presented with hyperammonemia due to inborn errors of metabolism who had continuous EEG and full medical records available for review, including follow up. RESULTS: Eight neonates with hyperammonemia were studied, 7 had urea cycle defects: Argininosuccinate lyase deficiency [3], (ornithine transcarbamylase deficiency [3], carbomyl phosphate synthase deficiency [1] and one had an organic acidemia: Methylmalonic acidemia [1]. Most common presentations were lethargy and poor feeding at 12-72 h of life. The highest blood ammonia level was 874 µmol/L (median); range 823-1647 µmol/L (normal value <50 µmol/L in term neonates). Seven were treated with hemodialysis in addition to nitrogen scavengers. Seven neonates had seizures; six had only electrographic seizures. Seizures initially occurred within 24-36 h of clinical presentation, sometimes with normal ammonia and glutamine levels. Neonates with seizures all lacked state changes on EEG. Inter burst interval duration correlated with degree of hyperammonemia. Two cases with normal plasma ammonia but increasing interburst interval duration were proven to have stroke by MRI. CONCLUSIONS: Seizures occur frequently in neonates with hyperammonemia; most can be detected only with continuous EEG. Seizures may occur when ammonia and glutamine levels are normal. Interburst interval duration is associated with ammonia levels or cerebral dysfunction from other brain pathology. Continuous EEG can be a useful tool for managing infants with hyperammonemia and may be essential for seizure management especially for infants in deep metabolic coma.


Asunto(s)
Amoníaco/sangre , Electroencefalografía , Hiperamonemia/sangre , Errores Innatos del Metabolismo/sangre , Convulsiones/sangre , Errores Innatos del Metabolismo de los Aminoácidos/sangre , Errores Innatos del Metabolismo de los Aminoácidos/diagnóstico por imagen , Errores Innatos del Metabolismo de los Aminoácidos/fisiopatología , Argininosuccinato Sintasa/sangre , Aciduria Argininosuccínica/sangre , Aciduria Argininosuccínica/diagnóstico por imagen , Aciduria Argininosuccínica/fisiopatología , Femenino , Glutamina/sangre , Humanos , Hiperamonemia/diagnóstico por imagen , Hiperamonemia/fisiopatología , Hipoxia-Isquemia Encefálica/sangre , Hipoxia-Isquemia Encefálica/diagnóstico por imagen , Hipoxia-Isquemia Encefálica/fisiopatología , Lactante , Recién Nacido , Masculino , Errores Innatos del Metabolismo/diagnóstico por imagen , Errores Innatos del Metabolismo/fisiopatología , Enfermedad por Deficiencia de Ornitina Carbamoiltransferasa/sangre , Enfermedad por Deficiencia de Ornitina Carbamoiltransferasa/diagnóstico por imagen , Enfermedad por Deficiencia de Ornitina Carbamoiltransferasa/fisiopatología , Convulsiones/diagnóstico por imagen , Convulsiones/fisiopatología
5.
Mol Genet Metab ; 95(1-2): 21-30, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18662894

RESUMEN

OBJECTIVE: To evaluate brain metabolism in subjects with partial ornithine transcarbamylase deficiency (OTCD) utilizing (1)H MRS. METHODS: Single-voxel (1)H MRS was performed on 25 medically-stable adults with partial OTCD, and 22 similarly aged controls. Metabolite concentrations from frontal and parietal white matter (FWM, PWM), frontal gray matter (FGM), posterior cingulate gray matter (PCGM), and thalamus (tha) were compared with controls and IQ, plasma ammonia, glutamine, and disease severity. RESULTS: Cases ranged from 19 to 59 years; average 34 years; controls ranged from 18 to 59 years; average 33 years. IQ scores were lower in cases (full scale 111 vs. 126; performance IQ 106 vs. 117). Decreased myoinositol (mI) in FWM (p=0.005), PWM (p<0.001), PCGM (p=0.003), and tha (p=0.004), identified subjects with OTCD, including asymptomatic heterozygotes. Glutamine (gln) was increased in FWM (p<0.001), PWM (p<0.001), FGM (p=0.002), and PCGM (p=0.001). Disease severity was inversely correlated with [mI] in PWM (r=-0.403; p=0.046) and directly correlated with [gln] in PCGM (r=0.548; p=0.005). N-Acetylaspartate (NAA) was elevated in PWM (p=0.002); choline was decreased in FWM (p=0.001) and tha (p=0.002). There was an inverse relationship between [mI] and [gln] in cases only. Total buffering capacity (measured by [mI/mI+gln] ratio, a measure of total osmolar capacity) was inversely correlated with disease severity in FWM (r=-0.479; p=0.018), PWM (r=-0.458; p=0.021), PCGM (r=-0.567; p=0.003), and tha (r=-0.345; p=0.037). CONCLUSION: Brain metabolism is impaired in partial OTCD. Depletion of mI and total buffering capacity are inversely correlated with disease severity, and serve as biomarkers.


Asunto(s)
Encéfalo/metabolismo , Imagen por Resonancia Magnética/métodos , Enfermedad por Deficiencia de Ornitina Carbamoiltransferasa/diagnóstico por imagen , Enfermedad por Deficiencia de Ornitina Carbamoiltransferasa/metabolismo , Adolescente , Adulto , Encéfalo/diagnóstico por imagen , Estudios de Casos y Controles , Femenino , Humanos , Inositol/metabolismo , Masculino , Persona de Mediana Edad , Enfermedad por Deficiencia de Ornitina Carbamoiltransferasa/diagnóstico , Radiografía , Índice de Severidad de la Enfermedad
6.
J Neuroimaging ; 12(1): 87-8, 2002 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11826609

RESUMEN

A 22-year-old woman with a negative urine drug screen and somnolence rapidly reversed by intravenous flumazenil was found to have elevated ammonia levels and punctate calcifications of the subcortical frontal white matter. Abnormally high levels of orotic acid were found in serum and urine, confirming the diagnosis of ornithine transcarbamylase deficiency. Although computed tomography findings are non-specific, young patients with unexplained hyperammonemic states of somnolence reversed by flumazenil should be screened for this X-linked recessive metabolic disorder.


Asunto(s)
Flumazenil/uso terapéutico , Moduladores del GABA/uso terapéutico , Enfermedad por Deficiencia de Ornitina Carbamoiltransferasa/diagnóstico por imagen , Enfermedad por Deficiencia de Ornitina Carbamoiltransferasa/tratamiento farmacológico , Adulto , Femenino , Humanos , Tomografía Computarizada por Rayos X
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA